Academy of Clinical Laboratory Physicians and Scientists

Nonprofit profile at a glance

EIN
237088244
IRS 990 coverage
2009–2024
Forms available
Form 990 2024
Location
Salt Lake City, UT, USA
Phone
8015832787
Rating
66
Verdict
SUPPORTED
Rating confidence
Moderate

Official website

Reported finances

Revenue
$93,017
Expenses
$68,356
Assets
$1,828,923
Liabilities
$0

Source: IRS Form 990. Selected filing: tax year 2024. Amounts in USD.

Leadership & pay

6 people listed

Executive titles in this filing

  • S WESLEY LONG (PRESIDENT)
  • RON JACKUPS MD PHD (PRESIDENT EL)

People named in this filing

  • GRACE KRONER (SECRETARY)
  • S WESLEY LONG (PRESIDENT)
  • ANGELLA CHARNOT-KASTIKAS MD (PAST PRESIDE)

Selected names, not a complete roster or a statement of current roles. Open leadership details for the complete filed list.

Source: IRS Form 990. Selected filing: tax year 2024. Names and roles reflect this filing, not necessarily current officeholders.

Overview

Mission

Our academy was founded in 1966 and currently has active affiliations with 70 of the approximately 150 academic and community training centers that train pathology residents in clinical pathology. From its origin, it has followed the mission statement of being dedicated to the advancement of teaching and scholarship in laboratory medicine. We follow the objectives of the academy. Since its inception, this dedication has been driven by the following objectives: 1. To encourage and advance the highest standards of education in laboratory medicine in medical school and related curricula. 2. To encourage and promote the highest standards of resident training and post-graduate education of physicians and scientists in clinical pathology at universities and medical schools. 3. To encourage and promote the highest standards of service, education and research in academic laboratory medicine.

What it reported doing in 2024

During the year that ended september 30, 2025, the academy provided services to approximately 400 active members and 220 associate members. More than 200 individuals attended the aclps annual meeting ("lab medicine") in atlanta, ga, on may 29-31, 2025. The meeting was hosted by emory university. Over the three days, conference attendees enjoyed scientific sessions, the award lectures from the cotlove and benson awardees, presentations from the young investigator award winners, the young faculty award winners and the strandjord grant awardees, and a poster session. The registration for this meeting was 700 for active members and 525 for associate members. The cotlove award was presented to dr. Wilbur lam who talked about "a pediatrician's adventures with point-of-care technologies in the lab and for the nih (as well as the rest of the country)". The benson award was presented to dr. Sixto leal who gave an update on "diagnostic, translational, and mechanistic studies in infectious disease pathology." the academy also continued the paul e. Strandjord young investigator grant program this year and provided two 7,500 research grants to program awardees in 2025. Aclps had initiated a series of articles titled " aclps the essentials " published in ajcp to discuss a challenging contemporary topic in the field through a case-based format. In addition, as a member of the rise first clinical pathology section, aclps education committee evaluated questions for the clinical pathology portion of the exam. Aclps continued to support co-sponsored educational sessions at the ascp annual meeting. It is usually a one-hour session highlighting educational topics and/or innovative research in the field of laboratory medicine. The 2025 speaker was eric q konnick, md who talked about transforming cancer care with cell-free dna testing. Aclps continues to provide educational review articles for publication in the american journal of clinical pathology (ajcp).

Operating model

Revenue model
Mixed. Its operating money came from several sources; no one source provided a clear majority.
Distribution model
Hybrid. The nonprofit split its reported program spending across 70% for direct work, and 30% for grants.

The verdict

SUPPORTED - The filed numbers largely add up and most voting board members are independent. A relatively small share of available resources goes toward mission work and some filing-based governance responses are negative or unanswered.

Rating breakdown

  • Financial Efficiency: 56
  • Transparency & Controls: 83
  • Accountability: 70
  • Sustainability: 76
  • Growth: 20

Detailed rating inputs

Financial Efficiency

  • Mission deployment rate: 47.9%; rating input score 48
  • Program expense ratio: 87.4%; rating input score 87
  • Fundraising efficiency: Limited

Transparency & Controls

  • Consistency checks: 91.7%; rating input score 92; 22nd percentile among comparable filings
  • Pay-setting controls: Limited
  • Foreign activity oversight: Limited
  • Grant itemization coverage: 84.3%; rating input score 84; 52nd percentile among comparable filings
  • Major donor itemization: Limited
  • Related-party transparency: Limited

Accountability

  • Independent voting board: 100%; rating input score 100; 64th percentile among comparable filings
  • Governance controls: 2 of 7 controls in place; rating input score 29
    • Conflict-of-interest policy: Fail
    • Whistleblower policy: Fail
    • Document-retention policy: Fail
    • CEO compensation review process: NotApplicable
    • Other executive compensation review process: NotApplicable
    • Form 990 shared with the board: Pass
    • Board meeting minutes documented: Pass
    • Audit committee oversight: Missing
    • Independent financial-statement audit: Fail

Sustainability

  • Operating margin: 26.5%; rating input score 77; 77th percentile among comparable filings
  • Total-asset coverage ratio: 26.76; rating input score 84; 84th percentile among comparable filings
  • Liabilities to assets ratio: 0; rating input score 69; 69th percentile among comparable filings
  • Officer compensation ratio: 0%; rating input score 60; 60th percentile among comparable filings

Growth

  • Program expense growth: -11.5% per year; rating input score 0; 26th percentile among comparable filings
  • Revenue growth: -4.6% per year; rating input score 0; 44th percentile among comparable filings
  • Asset growth: 4.2% per year; rating input score 100; 62nd percentile among comparable filings

Details

  • Where the money goes: 47.9% of revenue deployed · 87.4% of spending went to programs
  • Governance: 6 of 6 board members independent · 2 of 7 filing controls reported
  • Programs: 1 filed program accomplishment · $60K in reported program spending
  • Leadership: top reported pay $0 · 6 people listed
  • Consistency: 21 of 22 current checks pass · 1 finding to review
  • Schedules: 4 filed schedules · includes grants
  • Filing history: 16 filing years from 2009 to 2024
  • Contacts: How to reach this organization
  • Money network: 2 filed money-flow records
  • Grant readiness: Federal tax and exclusion status, award history, and grant-maker relationships.
  • People: Everyone the filings name, and which of them the filings identify by more than a name.

Key Signals

Signals prioritize questions for review. They are not findings of misconduct.

  • Moderate — Financial Efficiency: Mission deployment rate scored 48/100.
  • High — Accountability: Governance controls: 4 of 6 not reported.
  • High — Growth: Program expense growth scored 0/100.
  • High — Growth: Revenue growth scored 0/100.
  • Review — Transparency & Controls: Domestic grant itemization did not reconcile in the filed values.